A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
Clinical trial NCT00232180 · COMPLETED
Trial details
- NCT number
- NCT00232180
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 2743
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.